Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum

Impact · against what's priced in

MMSI shares are likely to see a positive catalyst due to an upward revision of organic revenue guidance to 7-7.5% and the announcement of a forthcoming long-range plan. However, management's explicit warning that future margin expansion will not match the scale of the previous several years prevents a more bullish outlook.

MMSI+0.50

No priced-in read yet